Age-related macular degeneration is a leading cause of central vision loss among older adults. It comes in two forms – dry and wet – both associated with visual impairment. Nearly

Treatment for AMD typically entails slowing its progression and improving vision. There are various options available. AMD damages the retina, which is an extremely thin tissue located at the back

Macular degeneration is an eye condition that causes progressive vision loss over time, impacting the central portion of your retina known as the macula, which helps you see straight lines

A one-time injection may improve vision more quickly and cost-effectively than existing therapies for wet macular degeneration. Once, the best available treatment for wet macular degeneration was monthly or bimonthly

Macular degeneration occurs when the macula, the central portion of your eye, becomes impaired, which can impair reading ability as well as face recognition. Dry AMD is the most prevalent

Antioxidants and zinc may help slow vision loss due to dry AMD. Meanwhile, faricimab-svoa (Vabysmo), an innovative new drug which blocks chemical processes responsible for wet AMD formation by blocking

Macular degeneration refers to any condition wherein there is a gradual deterioration or breakdown of your macula, the small region at the back of your eye that provides central vision.

Macular Degeneration can lead to gradual vision loss; this decline can be mitigated with vitamins or laser treatment. Macular degeneration can be divided into two distinct categories, dry and wet.